The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
Chad M. Ruoff, MD1; Michael J. Thorpy, MD2; Laura B. Herpel, MD3,4; Sarah Meskill, MD5; Michelle Vu, PharmD, MPH6; Erin Buysman, MS6; Diana Carino, PharmD, CSP, AAHIVP7; Brian Abaluck, MD8; Jennifer Gudeman, PharmD9,a
1Mayo Clinic, Phoenix, AZ, USA; 2Albert Einstein College of Medicine, New York, NY, USA; 3Bogan Sleep Consultants, Columbia, SC, USA; 4Medical University of South Carolina, Charleston, SC, USA; 5Tricoastal Narcolepsy and Sleep Disorders Center, Sugar Land, TX, USA; 6Optum Life Sciences, Eden Prairie, MN, USA; 7Optum Frontier Therapies, Las Vegas, NV USA; 8Alkermes, Inc., Waltham, MA, USA*; 9Avadel Pharmaceuticals, Chesterfield, MO, USA; aAt the time of the study
